Search PubMed⌕ Search

Biomedical subjects

G K Svensson

Publications and source records attributed to G K Svensson.

At least 19 recordsLinked to original sources
PubMed1994

Coumarin chemical dosimeter for radiation therapy.

Aqueous coumarin was investigated as a possible dosimeter for radiation therapy applications. Coumarin-3-carboxylic acid in aqueous solutions converts upon irradiation to the highly fluorescent 7-hydroxy-coumarin-3-carboxylic acid. The intensity of the fluorescence signal is linearly proportional to the number of the formed 7-hydroxy-coumarin-3-carboxylic acid molecules, which in turn is proportional to the radiation-absorbed dose. Basic characterization of the dosimetric properties (linearity with dose, energy and dose-rate dependence, postirradiation stability, and reproducibility) was performed. The system exhibits nearly linear behavior with dose, in the range of 0.1 to 50 Gy, is stable for at least 166 days following the irradiation, is reproducible within the same solution (+/- 2%) and is energy independent for 6- to 15-MV x-ray energies. A reduction of 18% of the fluorescence signal was observed by changing the dose rate from 0.8 to 4 Gy/min. The origin of the dose-rate effect was investigated and attributed to impurities, predominantly transition metal ions. Removing the impurities by recrystallization of the coumarin and using ultrahigh-purity water reduced the dose-rate dependency to less than 4% in the examined dose-rate range (0.8-4 Gy/min).

Biophysical Phenomena↗
PubMed1993

Effect of set-up error on the dose across the junction of matching cranial-spinal fields in the treatment of medulloblastoma.

PURPOSE: The effect of systematic and stochastic setup error on the dose delivered to the gap region for the three field radiation treatment of medulloblastoma is studied. The consequences of such setup error is discussed. METHODS AND MATERIALS: The treatment of medulloblastoma is typically a 3 field technique, in which two lateral cranial fields are matched with a spine field. The x-ray dose delivered to the region between the matched fields depends upon the gap size. The choice of the gap width between the cranial and spinal fields is controversial. It is currently a compromise between minimizing the risk of dose hot spots to the spine, and the associated clinical complications, as well as the magnitude of cold spots (underdosing) across the gap, with the associated risk of disease recurrence. In this paper, we examine the effect of gap width with a moving junction, referred to as "field feathering", on the dose across the field junction for a 6MV photon beam. In addition, we have studied 129 portal films and 40 simulation films to assess the accuracy and precision of patient setup during treatment with a plan involving feathered fields. Selected landmarks observable on both portal and simulation films were identified and the variation in the distances to the field edges measured. The distribution of patient setup error was convoluted with the beam profiles for a 6MV linac. These convoluted field edges were used obtain dose profiles across the gap region as a function of gap separation. The consequences for therapy are discussed. In addition, analysis of patient setup error on an alternative treatment involving beam modifiers to broaden the beam penumbra is discussed. RESULTS: The magnitude of the spatial stochastic and systematic setup error was determined to be approximately three and two millimeters respectively. The dosimetric consequences of patient setup error lead to over and under dosing in the spinal gap region for the three field technique. The degree of under or over dose depends on the nature and magnitude of the patient setup error. CONCLUSIONS: The effect of patient setup error can lead to significant dosimetric errors in the dose to the gap region depending on the magnitude of the setup errors. The effective over and under dose can be compensated by the use beams modifiers such as a beam spoiler or vibrating jaws.

Calibration↗
PubMed1993

Dynamic field shaping for stereotactic radiosurgery: a modeling study.

PURPOSE: This work assesses the relative field shaping advantages of dynamic field shaping devices for stereotactic radiosurgery using a linear accelerator. METHODS AND MATERIALS: We selected 43 intracranial tumors (2.0-4.2 cm maximum dimension, 1.5-25.5 cc tumor volume) out of the first 64 intracranial tumors treated with radiosurgery at the Joint Center for Radiation Therapy. We modeled five field shaping devices, each including a fixed auxiliary circular collimator: (a) fixed circular collimator alone; (b) two independent parallel jaws; (c) four independent rectangular jaws; (d) four independent rotatable jaws; and (e) "ideal" multileaf collimator. We adjusted the model parameters until the minimum target isodose was 80% of the dose delivered to isocenter. We defined the treatment volume ratio as the target volume divided by the treatment volume (volume receiving at least the minimum target dose). We used the treatment volume ratio to compare the five models and the actual patient treatments. RESULTS: For 34 tumors originally treated with one isocenter, the median Treatment Volume Ratio was higher for all of the device models except the fixed circular collimator compared to the actual patient treatments. For the nine tumors originally treated with multiple isocenters, the median Treatment Volume Ratio for the actual multiple isocenter treatments was similar to that for two parallel jaws, four rectangular jaws and four rotatable jaws. Only the median "ideal" collimator treatment volume ratio was higher for these nine tumors. CONCLUSION: Simple field shaping devices have approximately 50% of the conformal advantage of an "ideal" multileaf collimator. Approximately 50% of typical radiosurgical tumors between 2 and 4 cm have field shaping advantages which exceed the geometrical uncertainties inherent in linear accelerator radiosurgery treatments. The three models, two parallel, four rectangular, or four rotatable independent jaws would improve current linear accelerator technology by providing homogeneous doses with equivalent field shaping for most tumors originally treated with inhomogeneous multiple isocenter plans (6/9 tumors in the current series).

Brain Neoplasms↗
PubMed1993

Local hyperthermia, radiation therapy, and chemotherapy in patients with local-regional recurrence of breast carcinoma.

We retrospectively reviewed the response rate and the acute and long-term toxicity of combined treatment using radiation therapy, hyperthermia, and chemotherapy in 29 patients with locally or regionally recurrent or advanced adenocarcinoma of the breast who completed at least 4 of the 6 prescribed hyperthermia treatments as part of a Phase I-II trial. Thirty-nine separate hyperthermia treatment fields were evaluated. Cisplatin alone or cisplatin with etanidazole or bleomycin was delivered just prior to hyperthermia once weekly. Hyperthermia was delivered to a target minimum tumor temperature of 43 degrees C +/- 0.5 for 60 min. Following hyperthermia, a 400 cGy fraction of radiation was given. The radiation fraction size on other days was 200 cGy. Twenty-two fields had previously been irradiated and 17 fields had not. Prior chemotherapy had been given in 24 of 29 patients (83%) and hormonal therapy given in 21 (72%). The median follow-up time is 10 months; 16/29 patients (55%) have died of disease. The overall complete response rate for all fields was 53%. Response rate was not related to any clinical factor, radiation dose, microwave or ultrasound technique, type of chemotherapy, or tumor temperatures, but the number of patients in the study population was small. A statistically significant association between the likelihood of complications and the total radiation therapy dose (previous radiation and present radiation) was found. Persistent ulceration lasting greater than 1 month after completing treatment was seen in 67% of previously irradiated fields compared to 21% of fields that had not been previously treated (p = 0.015). Surgical wound repair was needed for 38% of fields with a history of prior irradiation versus 6% of those without prior treatment (p = 0.050). A statistically significant radiation therapy dose response was found for the likelihood of these complications. None of the hyperthermia temperature parameters studied correlated with an increased risk of complication. We conclude that the combination of radiation therapy, hyperthermia, and chemotherapy results in a high rate of complete response. However, in patients who have been treated with prior radiation therapy, this combination may be more locally toxic than treatment with hyperthermia and radiation therapy alone. The precise impact of chemotherapy on the therapeutic index of hyperthermia and radiation therapy remains to be determined in randomized clinical trials.

Adenocarcinoma↗
PubMed1991

Quality assurance in stereotactic radiosurgery using a standard linear accelerator.

Methods have recently been developed for using standard linear accelerators to perform stereotactic radiosurgery. The accuracy necessary to perform this procedure requires an intensive quality assurance program to encompass all aspects of dose calibration and mechanical integrity of the treatment unit, the treatment planning process, and treatment delivery. The programs developed at the Joint Center for Radiation Therapy (JCRT) include testing of the linear accelerator and the stereotactic system, cross checking of the treatment planning process, and a quality assurance check list of the treatment delivery procedure. This report outlines in detail the quality assurance program currently in use at the JCRT.

Humans↗
PubMed1988

An external beam treatment technique for retinoblastoma.

The main difficulty in the irradiation of retinoblastoma has been to deliver a high uniform dose to the entire retinal surface and spare the lens. Conventional techniques are inadequate to deliver an acceptable dose distribution especially for cases when there are both anterior and posterior lesions. We have developed a procedure to deliver a high dose anteriorly at the ora serrata for a compromise of about 30-35% of the target dose to the lens. The technique consists of 3 pairs of non-coplanar arcs using a 4 MV accelerator. This technique may offer a higher probability of tumor control and cure when gross tumor is present at the ora serrata when compared to the conventional techniques using lateral techniques.

Eye Neoplasms↗
PubMed1987

Measurements of dose distributions in small beams of 6 MV x-rays.

Dose distributions produced by small circular beams of 6 MV x-rays have been measured using ionisation chambers of small active volume. Specific quantities measured include tissue maximum ratios (TMR), total scatter correction factors (St), collimator scatter correction factors (Sc) and off-axis ratios (OAR). Field sizes ranged from 12.5 to 30 mm diameter, and were defined by machined auxiliary collimators with the movable jaws set for a 4 cm x 4 cm field size. Due to the lack of complete lateral electronic equilibrium for these small fields, the accuracy of the measurements was also investigated. This was accomplished by studying dose response as a function of detector size. Uncertainties of 2.5% were observed for the central axis dose in the 12.5 mm field when measuring with an ionisation chamber with a diameter of 3.5 mm. The total scatter correction factor exhibits a strong field size dependence for fields below 20 mm diameter, while the collimator scatter correction factor is constant and is defined by the setting of the movable jaws. Off-axis ratio measurements show larger dose gradients at the beam edges than those achieved with conventional collimator systems. Corrected profiles measured with an ionisation chamber are compared with measurements made with photographic film and LiF thermoluminescent dosemeters.

Humans↗
PubMed1985

A beam alignment device for matching fields.

When radiation treatment is delivered to adjacent or contiguous tumor volumes with multiple fields, the geometric alignment of the beams is particularly critical. A beam alignment device has been developed that enables precise matching of such fields.

Breast Neoplasms↗
PubMed1985

Progress in 3-D treatment planning for photon beam therapy.

The purpose of this report is to study the feasibility of improving dose distributions using non-coplanar photon beams from a linear accelerator. Non-coplanar beams may enter the patient in any arbitrary configuration. This type of treatment technique requires a three-dimensional (3-D) planning system. Clinical examples are used to illustrate the general problems in 3-D treatment planning, and the potential improvement over coplanar beam treatments. Features of a treatment planning system for 3-D planning are discussed.

Brain Neoplasms↗
PubMed1984

Quality assurance in radiation therapy: physics efforts.

During the last two years, several important documents on quality assurance in radiation therapy have been published. In 1981 the Committee on Radiation Oncology Studies, in a report to the Director of the National Cancer Institute, outlined criteria for multidisciplinary cancer management, including technical standards in radiation therapy. In March 1983, a task group of the American Association of Physicists in Medicine (AAPM) submitted a document for review and publication on "The Physical Aspects of Quality Assurance in Radiation Therapy". This document addresses quality assurance problems related to: 1. treatment machines; 2. measurement equipment; 3. treatment planning; 4. treatment verification; 5. brachytherapy; and 6. radiation safety. One chapter in this latter document discusses the problem of estimating the uncertainty in dose delivered to a patient. The contributions to this uncertainty are analyzed and separated into dosimetric and spatial uncertainties. The dosimetric uncertainties resulting from the central axis calibration and treatment planning amount to about 5% at the 95% confidence level in an optimal situation. The spatial uncertainties resulting from machine alignment problems combined with patient set-up and organ motion may be about 8 mm to 10 mm, corresponding to two standard deviations. An example of how the spatial uncertainty translates into a dose uncertainty for a three-field esophageal plan is discussed.

Humans↗
PubMed1983

Three-field technique for breast irradiation using tangential field corner blocks.

A further modification of the three-field technique for the radiotherapy of the breast has been developed. Two isocentric opposing tangential fields encompass the breast, chest wall, and may include the internal mammary lymph nodes. The third, an anterior field, encompasses the axilla and supraclavicular areas. As with our previously reported techniques, the objectives of the present modification is to make the posterior edges of the tangential fields coplanar and to match the cephalad geometric edges of the tangential fields to the caudad geometric edge of the supraclavicular field. A half-beam block is used to shield the caudad half of the anterior field, thus producing a vertical transverse plane to which the tangential fields are matched. Small corner blocks are used on the cephalad edges of the tangential fields to produce the vertical edge necessary for matching to the anterior field. It is essential that the match between the tangential fields and the anterior field be geometrically correct to ensure both local control of disease and good cosmetic results. Two advantages of the present technique are the ease with which it can be carried out and the precision of the match plane without the use of cumbersome mechanical accessories.

Breast Neoplasms↗
PubMed1983

Measurements of dose from secondary radiation outside a treatment field.

Radiation dose to organs outside the radiotherapy treatment field can be significant and therefore is of clinical interest. We have made measurements of dose at distances up to 70 cm from the central axes of 5 X 5, 15 X 15 and 25 X 25 cm radiation fields of 300 kVp, 4 MV and 8 MV X rays, and 60Co gamma rays, at the surface and at depths in water of 5 and 10 cm. Contributions to the total secondary radiation dose from water scatter, machine (collimator) scatter and leakage radiation have been separated. We have found that the component of dose from water scatter can be described by a simple exponential function of distance from the central axis of the radiation field for all energies and field sizes. Machine scatter contributes 20 to 40% of the total secondary dose depending on machine, field size and distance from the field. Leakage radiation contributes very little dose, but becomes the dominant component at distances beyond 60 cm from the central axis. Estimates of the risk of second tumors in long term survivors indicate a small incremental increase above the natural incidence rate based on information from the 1980 BEIR Committee report.

Adult↗
PubMed1983

Dose optimization with computer-controlled gantry rotation, collimator motion and dose-rate variation.

The applications of a computer-controlled radiation therapy system to optimize dose distributions in two dimensions are explored. This study is limited to a target volume with constant cross-section along an axis parallel to the long axis of the patient. The machine components that are continuously varied during treatment are the dose rate, the gantry angle, and the four independent collimator jaws, two of which can cross the beam centerline. Basic control strategies, treatment planning and delivery techniques are illustrated with clinical examples. We conclude that the computer-controlled radiation therapy system can easily and reliably deliver dose distributions which are significantly better than those produced by conventional multiple-field techniques.

Computers↗
PubMed1982

Optimization of radiation therapy: integral-response of a model biological system.

Several radiotherapy treatment planning criteria have been proposed for dose distribution optimization. Here we present a simple mathematical model of an idealized biological system. From it we have derived an objective function designed to achieve an extremum for that particular plan which minimizes the probabilities of occurrence of unacceptable complications in healthy tissue and of recurrence or spread of disease. The model assumes that an organism is separable into physiologically discrete compartments or organs, each consisting of a set of microscopic functional units with their own dose-response characteristics. In analogy to the integral-dose, we define an integral-response parameter v as a measure of radiation-induced damage; the value of this v may be calculated for any given spatial distribution of dose in a compartment or organ. A Probability of Serious Complications function, PSC(v), then provides an estimate of the likelihood of occurrence of unacceptable complications. Special problems arising with paired organs (kidneys), "series" organs (spinal cord), and the recurrence and spread of disease are addressed. The PSC for the various organs and neoplasia can be combined to form a compound Complication Factor (CF) objective function; the lower the value of the CF, the better the overall plan. Prospects for making the model explicitly time/fractionation dependent, and for incorporating utility theoretic ideas, are discussed.

Humans↗